Anesthesia Risks & Emergency Precautions
At a Glance
Anesthesia carries life-threatening risks for people with Myotonic Dystrophy Type 1. The muscle relaxant succinylcholine must be strictly avoided as it triggers severe muscle contractions. Always carry a medical alert card and ensure your surgical team uses safe alternatives like Sugammadex.
For people living with Myotonic Dystrophy Type 1 (DM1), surgery and anesthesia are not “routine.” Even minor procedures requiring sedation carry significant risks that must be managed with extreme care [1][2]. Because your muscles, heart, and lungs all function differently due to DM1, your medical team must follow specific safety protocols to prevent life-threatening complications [3][4].
The Danger of a “Myotonic Crisis”
In DM1, certain triggers can cause a myotonic crisis—a sudden, severe, and generalized muscle contraction that can make it impossible to breathe or for a doctor to manage your airway [5][6].
- Medication Triggers: The muscle relaxant succinylcholine is strictly contraindicated because it can trigger these severe contractions and cause a dangerous spike in potassium (hyperkalemia), leading to cardiac arrest [5][7].
- Physical Triggers: Being cold (hypothermia), shivering, pain, or emotional stress can all trigger myotonia during or after surgery [8][1].
- Mechanical Triggers: Even the electrical stimulation used by anesthesiologists to monitor muscle relaxation (nerve stimulation) can sometimes trigger a contraction [8].
Reversing Anesthesia Safely
If your surgery requires muscle relaxants, your team should use “non-depolarizing” agents (like rocuronium) rather than succinylcholine [9][10]. When the surgery is over, these medications must be “reversed” so you can breathe on your own again.
- Why Sugammadex? Traditional reversal agents like neostigmine can sometimes make muscle weakness worse or even trigger myotonia in DM1 patients [11][12].
- The Preferred Choice: Sugammadex is widely preferred for DM1 patients because it works quickly and safely to reverse muscle relaxation without interfering with the body’s other chemical systems [13][14].
Essential Safety Checklist
Share this information with your surgeon and anesthesiologist well before any procedure:
- No Succinylcholine: Confirm that no “depolarizing” muscle relaxants will be used [5].
- Avoid Neostigmine: Request Sugammadex for reversal if muscle relaxants are necessary [14][13].
- Temperature Control: The operating room must be kept warm, and warming blankets should be used to prevent shivering [8].
- Cardiac Monitoring: Continuous ECG monitoring is vital due to the high risk of heart rhythm issues (arrhythmias) during surgery [15][1].
- Aspiration Precautions: Because DM1 can affect swallowing, there is a higher risk of inhaling stomach contents into the lungs (aspiration) during intubation [16].
Carry a Medical Emergency Card
Because many emergency room doctors and paramedics are unfamiliar with DM1, you should carry a Medical Emergency Card at all times [2]. This card should clearly list:
- Your diagnosis: Myotonic Dystrophy Type 1 (Steinert Disease).
- The warning: “NO SUCCINYLCHOLINE” in bold letters [5].
- Your risk of respiratory failure and the need for careful oxygen monitoring [4].
- Your risk of cardiac conduction blocks or arrhythmias [3].
- Contact information for your primary neurologist or DM1 specialist.
Common questions in this guide
Why is anesthesia dangerous for people with Myotonic Dystrophy Type 1?
What is a myotonic crisis during surgery?
Which anesthesia medications should be avoided if I have Steinert disease?
What is the safest anesthesia reversal agent for DM1?
Why do I need to stay warm during surgery?
What should I put on my medical emergency card for DM1?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are you aware of the specific anesthesia precautions required for patients with Myotonic Dystrophy Type 1?
- 2.How will you monitor my heart and breathing during and immediately after the procedure?
- 3.Can we ensure that sugammadex is available as the reversal agent if I need a muscle relaxant?
- 4.What steps will you take to keep me warm in the operating room to prevent myotonia from shivering?
- 5.How will you assess my breathing and swallow function before I am cleared to go home?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Laparoscopic cholecystectomy under total intravenous anaesthesia in a patient with myotonic dystrophy type 1 (Steinert's disease) - a case report.
Karras G, Nikouli E, Kiamiloglou B
Folia medica 2022; (64(2)):333-336 doi:10.3897/folmed.64.e59905.
PMID: 35851789 - 2
[Medical emergency card for Steinert's disease: an unmet need].
Rosado-Bartolomé A, Domínguez-González C
Revista de neurologia 2023; (76(1)):15-19 doi:10.33588/rn.7601.2022380.
PMID: 36544372 - 3
Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value.
Russo V, Capolongo A, Bottino R, et al.
Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051947.
PMID: 36902735 - 4
Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.
Gallinoro E, Papa AA, Rago A, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(3)):227-231.
PMID: 30838353 - 5
Complications After Dental Sedation: A Myotonic Mystery Case Report.
Karamlou M, Asaria I, Barron J, et al.
Anesthesia progress 2022; (69(4)):26-31 doi:10.2344/anpr-69-02-09.
PMID: 36534775 - 6
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia.
Wadhwani AR, Aggarwal A, Loscalzao S, et al.
Neurology 2025; (104(8)):e213497 doi:10.1212/WNL.0000000000213497.
PMID: 40127393 - 7
Suxamethonium-Induced Hyperkalemia: A Short Review of Causes and Recommendations for Clinical Applications.
Hovgaard HL, Juhl-Olsen P
Critical care research and practice 2021; (2021()):6613118 doi:10.1155/2021/6613118.
PMID: 33708444 - 8
[Opioid-free general anesthesia and induced recovery from anesthesia in a patient with myotonic dystrophy type-1: a case report].
Gurbuz H, Saracoglu KT
Brazilian journal of anesthesiology (Elsevier) 2020; (70(6)):682-685 doi:10.1016/j.bjan.2020.07.004.
PMID: 33190906 - 9
Prevalence and associated factors of postoperative suxamethonium-induced myalgia in surgical patients at Debre Tabor Comprehensive Specialized Hospital Ethiopia: a cross-sectional study.
Chekol B, Zurbachew N, Mekete G, et al.
Scientific reports 2024; (14(1)):16552 doi:10.1038/s41598-024-65779-7.
PMID: 39019942 - 10
Comparison between succinylcholine and rocuronium as neuromuscular blocking agents for electroconvulsive therapy in a patient with pseudocholinesterase deficiency.
Takazawa T, Suto T, Aihara M, et al.
JA clinical reports 2015; (1(1)):7 doi:10.1186/s40981-015-0009-2.
PMID: 29497639 - 11
Myasthenia gravis and sugammadex: A case report and review of the literature.
Dontukurthy S, Wisler C, Raman V, Tobias JD
Saudi journal of anaesthesia 2020; (14(2)):244-248 doi:10.4103/sja.SJA_721_19.
PMID: 32317886 - 12
Sugammadex for Reversal of Neuromuscular Blockade: Uses and Limitations.
Hawkins J, Khanna S, Argalious M
Current pharmaceutical design 2019; (25(19)):2140-2148 doi:10.2174/1381612825666190704101145.
PMID: 31272347 - 13
Preparing for the unexpected: special considerations and complications after sugammadex administration.
Iwasaki H, Renew JR, Kunisawa T, Brull SJ
BMC anesthesiology 2017; (17(1)):140 doi:10.1186/s12871-017-0429-9.
PMID: 29041919 - 14
Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
Togioka BM, Schenning KJ
Drugs & aging 2022; (39(10)):749-761 doi:10.1007/s40266-022-00969-4.
PMID: 35934764 - 15
[Myotonic dystrophy type 1 - a rare cause of bradycardia in the young].
Kataja Knight A, Tidehag L, Mattsson G, Magnusson P
Lakartidningen 2020; (117()).
PMID: 31961442 - 16
Silent dysphagia in two patients with Steinert disease and recurrent respiratory exacerbations.
Annunziata A, Valente T, Cauteruccio R, Fiorentino G
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(3)):141-143 doi:10.36185/2532-1900-019.
PMID: 33305171
This page provides general anesthesia safety guidelines for Myotonic Dystrophy Type 1 for educational purposes. Always consult with your anesthesiologist and surgical team to develop a personalized, safe surgical plan.
Get notified when new evidence is published on Steinert myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.